TrialArthritis research & therapy2019

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial.

Henriëtte M Y de Jong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.